Vimarsana
Biggest News Aggregation in the World

Simonea Minnie News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Simonea Minnie. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Simonea Minnie Today - Breaking & Trending Today

iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology Annual Meeting and TIGIT Therapies Digital Summit - Vimarsana News

iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology Annual Meeting and TIGIT Therapies Digital Summit

Published: December 14, 2021

Data from preclinical studies in collaboration with Fred Hutchinson Cancer Research Center will be presented at ASH and provide strong rationale for use of EOS-448 as a single agent and in combination with an immunomodulatory drug in patients with multiple myeloma Preclinical data shared at TIGIT Therapies Digital S...

Source: pharmiweb.com
Related Topics:
United KingdomUnited StatesWaals GewestPhilippe MoreauBristol Myers Squibb ImiMichel DetheuxGregory DriessensBryan BakerSimonea MinnieNantes University HospitalTeos Therapeutics IncClinical Research DivisionExchange CommissionTrademark OfficeAmerican Society Of HematologyHematology DepartmentFred Hutchinson Cancer Research CenterDigital SummitTeos TherapeuticsAmerican SocietyAnnual MeetingFred Hutchinson Cancer ResearchRefractory MultipleBristol Myers SquibbSenior Director
Neoleukin Therapeutics Announces Preclinical Data - Vimarsana News

Neoleukin Therapeutics Announces Preclinical Data

Published: December 11, 2021

– Poster presentation highlights NL-201 activity in multiple myeloma stem cell transplant model – – Abstract reports activity of NL-201 as monotherapy and...

Source: globenewswire.com
Related Topics:
United StatesPriti PatelJulie RathbunAlexandra RoySimonea MinnieExchange CommissionAmerican Society Of HematologyNeoleukin Therapeutics IncFred Hutchinson Cancer Research CenterAmerican SocietyAnnual MeetingChief Medical OfficerMyeloma RelapseExpanding Highly Cytolytict CellsBone MarrowDemonstrates Synergistic Antitumor ActivityInhibitor TherapyPreclinical Non Hodgkin LymphomaNeoleukin TherapeuticsForward Looking StatementsSecurities Litigation Reform ActNasdaq NltxNeoleukin Therapeutics
iTeos Therapeutics Inc.: iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology Annual Meeting and TIGIT Therapies Digital Summit 2021 - Vimarsana News

iTeos Therapeutics Inc.: iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology Annual Meeting and TIGIT Therapies Digital Summit 2021

Published: December 9, 2021

Data from preclinical studies in collaboration with Fred Hutchinson Cancer Research Center will be presented at ASH and provide strong rationale for use of EOS-448 as a single agent and in combination

Source: finanznachrichten.de
Related Topics:
United StatesUnited KingdomWaals GewestPhilippe MoreauBristol Myers Squibb ImiMichel DetheuxGregory DriessensBryan BakerSimonea MinnieNantes University HospitalTrademark OfficeExchange CommissionTeos Therapeutics IncHematology DepartmentClinical Research DivisionFred Hutchinson Cancer Research CenterDigital SummitFred Hutchinson Cancer ResearchRefractory MultipleBristol Myers SquibbSenior DirectorProject HeadTeos TherapeuticsPrivate Securities Litigation Reform ActUnited States Patent